$7.3
+0.14
(+1.96%)▲
1.51%
Downside
Day's Volatility :3.1%
Upside
1.62%
62.19%
Downside
52 Weeks Volatility :85.63%
Upside
61.98%
Period | Canopy Growth Corporation | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -19.64% | 6.5% | 0.0% |
6 Months | 57.02% | 7.1% | 0.0% |
1 Year | 78.33% | 9.8% | 0.0% |
3 Years | -96.37% | 14.2% | -20.2% |
Market Capitalization | 754.9M |
Book Value | $5.49 |
Earnings Per Share (EPS) | -4.7 |
Wall Street Target Price | 4.31 |
Profit Margin | -221.19% |
Operating Margin TTM | -45.48% |
Return On Assets TTM | -4.31% |
Return On Equity TTM | -76.74% |
Revenue TTM | 297.1M |
Revenue Per Share TTM | 3.97 |
Quarterly Revenue Growth YOY | 6.7% |
Gross Profit TTM | -81.9M |
EBITDA | -75.8M |
Diluted Eps TTM | -4.7 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -4.21 |
EPS Estimate Next Year | -0.94 |
EPS Estimate Current Quarter | -0.33 |
EPS Estimate Next Quarter | -0.25 |
What analysts predicted
Downside of 40.96%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 169.6M | ↑ 190.37% |
Net Income | -502.1M | ↑ 1137.84% |
Net Profit Margin | -296.06% | ↓ 226.61% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 283.3M | ↑ 76.18% |
Net Income | -985.5M | ↑ 107.05% |
Net Profit Margin | -347.93% | ↓ 51.87% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 435.1M | ↑ 37.08% |
Net Income | -1.3B | ↑ 20.42% |
Net Profit Margin | -305.65% | ↑ 42.28% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 416.9M | ↓ 4.82% |
Net Income | -256.8M | ↓ 80.82% |
Net Profit Margin | -61.59% | ↑ 244.06% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 298.0M | ↓ 22.57% |
Net Income | -2.4B | ↑ 932.67% |
Net Profit Margin | -821.42% | ↓ 759.83% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 219.5M | ↓ 26.25% |
Net Income | -485.5M | ↓ 80.14% |
Net Profit Margin | -221.19% | ↑ 600.23% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 74.8M | ↓ 14.13% |
Net Income | -197.0M | ↑ 15.01% |
Net Profit Margin | -263.53% | ↓ 66.77% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 64.7M | ↓ 13.51% |
Net Income | -478.9M | ↑ 142.8% |
Net Profit Margin | -739.83% | ↓ 476.3% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 82.1M | ↑ 24.21% |
Net Income | -28.8M | ↓ 94.11% |
Net Profit Margin | -35.06% | ↑ 704.77% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 82.1M | ↓ 24.51% |
Net Income | -310.0M | ↑ 713.24% |
Net Profit Margin | -377.72% | ↓ 342.66% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 78.5M | ↓ 4.35% |
Net Income | -216.8M | ↓ 30.07% |
Net Profit Margin | -276.16% | ↑ 101.56% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 39.7M | ↓ 31.56% |
Net Income | -50.3M | ↓ 68.56% |
Net Profit Margin | -126.86% | ↑ 149.3% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.5B | ↑ 507.72% |
Total Liabilities | 1.1B | ↑ 669.9% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 4.9B | ↓ 21.46% |
Total Liabilities | 1.2B | ↑ 12.72% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 5.4B | ↓ 0.5% |
Total Liabilities | 2.5B | ↑ 90.59% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 4.5B | ↓ 17.71% |
Total Liabilities | 1.6B | ↓ 38.01% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.8B | ↓ 56.56% |
Total Liabilities | 1.2B | ↓ 15.39% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 960.4M | ↓ 46.69% |
Total Liabilities | 590.8M | ↓ 52.37% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.2B | ↓ 11.23% |
Total Liabilities | 1.2B | ↓ 9.08% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.8B | ↓ 19.24% |
Total Liabilities | 1.2B | ↑ 6.24% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.7B | ↓ 10.19% |
Total Liabilities | 1.0B | ↓ 20.01% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.7B | ↓ 23.84% |
Total Liabilities | 918.8M | ↓ 31.59% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 18.49% |
Total Liabilities | 815.1M | ↓ 11.28% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 709.0M | ↓ 29.41% |
Total Liabilities | 436.1M | ↓ 27.56% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -390.0M | ↑ 538.62% |
Investing Cash Flow | -2.4B | ↑ 1343.75% |
Financing Cash Flow | 4.4B | ↑ 1010.05% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -548.8M | ↑ 48.44% |
Investing Cash Flow | -246.9M | ↓ 89.23% |
Financing Cash Flow | -40.6M | ↓ 100.98% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -370.7M | ↓ 39.72% |
Investing Cash Flow | -703.7M | ↑ 154.31% |
Financing Cash Flow | 1.0B | ↓ 2312.64% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -437.3M | ↑ 17.19% |
Investing Cash Flow | 184.9M | ↓ 126.11% |
Financing Cash Flow | -36.5M | ↓ 103.6% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -106.3M | ↑ 7.87% |
Investing Cash Flow | 99.8M | ↑ 57.89% |
Financing Cash Flow | -98.6M | ↑ 1074.32% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -103.3M | ↓ 2.89% |
Investing Cash Flow | 105.4M | ↑ 5.51% |
Financing Cash Flow | 93.3M | ↓ 194.55% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -112.3M | ↑ 6.39% |
Investing Cash Flow | 107.7M | ↑ 0.0% |
Financing Cash Flow | -100.6M | ↓ 205.45% |
Sell
Neutral
Buy
Canopy Growth Corporation is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Canopy Growth Corporation | 7.99% | 57.02% | 78.33% | -96.37% | -97.94% |
![]() Neurocrine Biosciences Inc. | 7.56% | 2.78% | 45.55% | 52.55% | 67.01% |
![]() Haleon Plc Spon Ads | 7.53% | 11.87% | 3.28% | 23.35% | 23.35% |
![]() Zoetis Inc. | 5.77% | -5.62% | -5.85% | -9.99% | 57.03% |
![]() Viatris Inc. | 12.75% | -1.42% | 12.21% | -15.03% | -28.03% |
![]() Catalent, Inc. | 4.08% | 11.91% | 19.53% | -48.27% | 2.08% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Canopy Growth Corporation | NA | NA | NA | -4.21 | -0.77 | -0.04 | NA | 5.49 |
![]() Neurocrine Biosciences Inc. | 39.75 | 39.75 | 0.44 | 3.99 | 0.18 | 0.1 | NA | 23.72 |
![]() Haleon Plc Spon Ads | 29.9 | 29.9 | 1.69 | 0.39 | 0.07 | 0.04 | 0.02 | 1.8 |
![]() Zoetis Inc. | 34.62 | 34.62 | 2.58 | 5.77 | 0.5 | 0.14 | 0.01 | 11.07 |
![]() Viatris Inc. | 224.4 | NA | 0.06 | 2.73 | 0.0 | 0.03 | 0.04 | 16.81 |
![]() Catalent, Inc. | 211.02 | NA | 2.06 | 0.2 | -0.28 | -0.01 | NA | 19.96 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Canopy Growth Corporation | Sell | $754.9M | -97.94% | NA | -221.19% |
![]() Neurocrine Biosciences Inc. | Buy | $14.7B | 67.01% | 39.75 | 18.65% |
![]() Haleon Plc Spon Ads | Buy | $41.0B | 23.35% | 29.9 | 9.64% |
![]() Zoetis Inc. | Buy | $82.0B | 57.03% | 34.62 | 27.38% |
![]() Viatris Inc. | Hold | $14.2B | -28.03% | 224.4 | -0.37% |
![]() Catalent, Inc. | Hold | $10.6B | 2.08% | 211.02 | -28.44% |
Insights on Canopy Growth Corporation
Revenue is down for the last 4 quarters, 108.72M → 53.73M (in $), with an average decrease of 20.1% per quarter
Netprofit is up for the last 3 quarters, -310.01M → -68.16M (in $), with an average increase of 130.5% per quarter
In the last 3 years, Neurocrine Biosciences Inc. has given 52.6% return, outperforming this stock by 149.0%
Tidal Investments LLC.
Royal Bank of Canada
Morgan Stanley - Brokerage Accounts
Lord, Abbett & Co LLC
Bank of America Corp
Millennium Management LLC
canopy growth corporation is a world-leading diversified cannabis company. we operate a collection of diverse brands and curated strain variety, supported millions of square feet of indoor greenhouse production capacity, partnered with some of the leading names in the sector. here's to future growth.
Organization | Canopy Growth Corporation |
Employees | 1029 |
CEO | Mr. David Eric Klein |
Industry | Process Industries |
A Spac I Acquisition Corp
$7.30
+1.96%
Keyarch Acquisition Corp
$7.30
+1.96%
Connexa Sports Technologies Inc
$7.30
+1.96%
Us Value Etf
$7.30
+1.96%
First Wave Biopharma Inc
$7.30
+1.96%
Global X Msci Next Emerging
$7.30
+1.96%
Fat Projects Acquisition Corp
$7.30
+1.96%
Capital Link Global Fintech
$7.30
+1.96%
Applied Uv Inc
$7.30
+1.96%